Telix Pharmaceuticals TLX
NASDAQ TLX
$11.34 -0.28 (-2.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Receivables (2023 - 2026)

Updated

Telix Pharmaceuticals' Receivables came in at $163.56 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Receivables (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Receivables was $129.2 million, up 41.5% from the prior year.

  • Going back by year, Receivables was $91.33 million in the year ended Dec 31, 2024 (+114.8%) and $42.52 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Telix Pharmaceuticals 3.94 Bn 2.88 Bn - 163.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 163.56 Mn
Dec 31, 2025 129.20 Mn
Dec 31, 2024 91.33 Mn
Dec 31, 2023 42.52 Mn
API Access

Telix Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=TLX&period=max&api_key=YOUR_API_KEY